LDN-214117

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameLDN-214117
Drug Alias NameLDN-214117
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionActivin receptor type-1 inhibitors
TargetsActivin receptor type-1
Therapy Area/IndicationsMyositis Ossificans
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHarvard University
China Registration ClassN/A

Develop Information

Active CompaniesHarvard University
Inactive CompaniesN/A
Active IndicationsMyositis Ossificans
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A